MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JICAX88.35N/A
N/A
JPMorgan US Sustainable Leaders A
PLVIX20.70N/A
N/A
Principal Large Cap Value III Inst
ARSIX16.42N/A
N/A
AMG River Road Small Cap Value I
BLPIX92.53N/A
N/A
ProFunds Bull Inv
POGAX79.57N/A
N/A
Putnam Large Cap Growth A

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with IMUX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then IMUX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
+1.11%
IMUX - IRD
36%
Loosely correlated
-0.19%
ARRY - IRD
35%
Loosely correlated
-1.39%
ROIV - IRD
35%
Loosely correlated
+0.11%
PRME - IRD
33%
Poorly correlated
+2.59%
BEAM - IRD
31%
Poorly correlated
+1.31%
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com